Adverum Biotech

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag...Read more



Post IPO Equity




Org chart

Laurent Fischer
President & CEO
Richard Beckman
Chief Medical Officer
Brigit Riley
Chief Scientific Officer
Star Seyedkazemi
Chief Development Officer
John Rakow
General Counsel
Jim Wang
SVP & Head, Regulatory Affairs
Dena House
SVP, Human Resources, Organizational Development & Learning
Carla Fiankan
SVP, Regulatory Affairs
Heikki Jouttijärvi
SVP & Head, Technical Operations
Anand Reddi
VP & Head, Corporate Strategy & External Affairs & Engagement
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.